NFE2L2 and head and neck cancer: Together these data support a role for altered activation of the Oxidation pathway specifically the KEAP1-NRF2 pathway in not only recurrent laryngeal tumors, but also in Head and Neck cancers more broadly, and these results warrant further investigation in additional cohorts.